Immunological considerations for SARS-CoV-2 human challenge studies

Nature Reviews Immunology
Volume 20 Issue 12, December 2020
https://www.nature.com/nri/volumes/20/issues/12

 

Comment | 21 October 2020
Immunological considerations for SARS-CoV-2 human challenge studies
In this Comment article, Sandy Douglas and Adrian Hill discuss the immunological considerations associated with a risk–benefit analysis for controlled human infection models of SARS-CoV-2.
Alexander D. Douglas  & Adrian V. S. Hill